Who owns State Street SPDR S&P Pharmaceuticals ETF?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of XPH from SEC Form 13F filings across 94 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 94 institutions disclosed 3.9M shares of State Street SPDR S&P Pharmaceuticals ETF worth $262.5M — about 96.8% of shares outstanding; the largest disclosed holder is BANK OF AMERICA CORP /DE/. Source: SEC Form 13F filings, parsed by EvidInvest.
94
13F holders
$262.5M
value, 2026 filers
96.8%
of shares outstanding (3.9M sh)
26
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of XPH's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BANK OF AMERICA CORP /DE/ | 1.0M | $67.3M | 0.0% | 25.2% | +25.1% |
| 2 | WELLS FARGO & COMPANY/MN | 387,368 | $25.7M | 0.0% | 9.6% | -4.2% |
| 3 | Kingsview Wealth Management, LLC | 314,894 | $20.9M | 0.3% | 7.8% | +6.6% |
| 4 | MORGAN STANLEY | 314,226 | $20.8M | 0.0% | 7.8% | +9.3% |
| 5 | ENVESTNET ASSET MANAGEMENT INC | 221,822 | $14.7M | 0.0% | 5.5% | -18.2% |
| 6 | FIRST CITIZENS BANK & TRUST CO | 195,701 | $13.0M | 0.2% | 4.9% | +4.4% |
| 7 | Envestnet Portfolio Solutions, Inc. | 180,521 | $12.0M | 0.1% | 4.5% | +5.3% |
| 8 | LPL Financial LLC | 168,419 | $11.2M | 0.0% | 4.2% | +15.2% |
| 9 | CITIGROUP INC | 104,114 | $6.9M | 0.0% | 2.6% | +110.8% |
| 10 | Evelyn Partners Group LtdNEW | 71,806 | $10.5M | 0.0% | 1.8% | new |
| 11 | TRUIST FINANCIAL CORP | 70,678 | $4.7M | 0.0% | 1.8% | +1.4% |
| 12 | Measured Wealth Private Client Group, LLCNEW | 68,306 | $4.5M | 1.1% | 1.7% | new |
| 13 | Private Advisor Group, LLC | 63,697 | $4.2M | 0.0% | 1.6% | +14.2% |
| 14 | UBS Group AG | 55,346 | $3.7M | 0.0% | 1.4% | +13.2% |
| 15 | Cetera Investment Advisers | 49,004 | $3.2M | 0.0% | 1.2% | -14.5% |
| 16 | Wharton Business Group, LLC | 46,395 | $3.1M | 0.1% | 1.2% | 0.0% |
| 17 | SVB WEALTH LLCNEW | 42,797 | $2.8M | 0.2% | 1.1% | new |
| 18 | TWO SIGMA INVESTMENTS, LP | 35,751 | $2.4M | 0.0% | 0.9% | -29.5% |
| 19 | Clark Capital Management Group, Inc. | 32,929 | $2.2M | 0.0% | 0.8% | -24.0% |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 32,012 | $2.1M | 0.0% | 0.8% | -34.4% |
| 21 | MAI Capital Management | 31,119 | $2.1M | 0.0% | 0.8% | +9.1% |
| 22 | Baird Financial Group, Inc. | 28,468 | $1.9M | 0.0% | 0.7% | -2.0% |
| 23 | GTS SECURITIES LLC | 26,885 | $1.8M | 0.0% | 0.7% | -18.7% |
| 24 | Compass Wealth Management LLC | 26,652 | $1.8M | 0.3% | 0.7% | +10.3% |
| 25 | GOLDMAN SACHS GROUP INC | 26,231 | $1.7M | 0.0% | 0.7% | -0.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.